SUMMARY: Preimplantation genetic diagnosis makes it possible to detect and identify the genetic or chromosomal abnormalities (the abnormal chromosomal configuration and the abnormal genetic content), thus, selecting the healthy, top–quality embryos that have ultra–powerful implantation potential after the embryo transfer. PGD also turns it possible to prevent transferring the embryos that have “wrong” chromosomal configuration, “incomplete” or “dual” chromosomal content, those, that are mosaic, or those that carry the transmitted genetic disease.
PRICE: Preimplantation genetic diagnosis (PGD) package: Price on Request.
More details about Preimplantation genetic diagnosis (PGD) in FIV Marbella.
Preimplantation genetic diagnosis (PGD) is a powerful technique used for comprehensive embryonic “configuration” screening and embryonic portfolio designing of the embryos generated through IVF. Preimplantation genetic screening is done in the IVF laboratory only. This technique requires PRO IVF Microscopes and/or Inverted Flexible Platforms for IVF for a brilliant performance. Performance is the leading feature for capturing, identification and validation of the chromosomal configuration and visualization of the genetic content. With great VISUALIZING POWER comes great capability for 99% result–validation accuracy. IVF Inverted Microscopes with flexible platforms elevate the Microscope to a whole new level of performance and portability. Plus, the image–capturing extreme–modes that are installed into the Microscopes software, allow all possible virtual “touches” — to drag and drop the investigated content for 99% of pre–implantation diagnosis accuracy.
PGD screening is performed in all cases with (1) suspected increased risk of abnormal chromosomal content (abnormal chromosomal “configuration”), (2) “tagged” with recurrent miscarriages, (3) advanced maternal age, (4) repeated IVF failures, (5) and in cases of altered male meiosis.
It is also performed in couples carrying transmitted sex–linked diseases and in couples with alterations in their karyotype (translocations, inversions, etc.). In these cases, PGD is performed to prevent the transmission of certain genetic diseases (monogenic diseases), including some muscular dystrophies, cystic fibrosis or Thalassemia.